Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Arjun Handa

    Jump to

    • Income-Tax Dept searches 20 premises of Claris Lifesciences

    • Budget 2015 gave good road map: Arjun Handa

    • Athanas Enterprises buys 3.15cr shares of Claris Life

    • Claris Lifesciences tanks post sale of infusions biz to JV

      Claris Lifesciences shares plunged over 5 percent on Friday, after the company said it would transfer its infusions business, which accounted for more than half of its revenue, to a joint venture with Japan's Otsuka Pharmaceutical Factory and Mitsui & Co for Rs 1,050 crore in cash.

    • Confident of resolving USFDA issue soon: Claris Life

      Speaking to CNBC-TV18, Arjun Handa, managing director & CEO of Claris Lifesciences said."We have had very productive meeting with the US FDA and are hopeful of resolving the issue very soon. We don’t see this as very big hurdle for the company."

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347